Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

類似資料

• Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
  著者:: Stewart, Michelle, 等
  出版事項: (2015)
• Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
  著者:: Li, Benjamin, 等
  出版事項: (2020)
• Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
  著者:: Keohane, Denis, 等
  出版事項: (2015)
• Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
  著者:: Romero-Imbroda, Jesús, 等
  出版事項: (2017)
• Genotype and Phenotype of Transthyretin Cardiac Amyloidosis in the United States: The Transthyretin Amyloid Outcome Survey (THAOS)
  著者:: Maurer, Mathew S., 等
  出版事項: (2016)